Organon
About Organon
Organon is a company based in Jersey City (United States) was acquired by Merck in November 2007. It operates as a Direct-to-Consumer (D2C), and Professional Services. Organon has completed 4 acquisitions, including Alydia Health, Dermavant and Forendo Pharma. Organon offers products and services including Women's Health Solutions, Biosimilars, and Established Brands. Organon operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Jersey City, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Organon & Co.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Alydia Health
& 3 more
-
Acquired by
Merck
(Nov 22, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Organon
Organon is a publicly listed company on the NYSE with ticker symbol OGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Organon
Organon offers a comprehensive portfolio of products and services, including Women's Health Solutions, Biosimilars, and Established Brands. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Solutions for women's reproductive and maternal health are provided.
Accessible treatment options through biosimilars are made available.
Therapies for various conditions like cardiovascular are offered.
Unlock access to complete
Unlock access to complete
Leadership Team
88 people
Software Development Team
55 people
Finance and Accounting
29 people
Data Analysis and Operations Team
22 people
Legal and Compliance
19 people
Operations Team
17 people
Product Management Team
15 people
Human Resources and Administration
14 people
Unlock access to complete
Funding Insights of Organon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Organon
Organon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merck. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical products are manufactured and marketed worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Organon
Organon has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Alydia Health, Dermavant and Forendo Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Postpartum hemorrhage is controlled via vacuum-induced uterine contraction devices.
|
2020 | ||||
|
Small molecule therapeutics for inflammatory skin diseases are developed.
|
2016 | ||||
|
Small molecule therapeutics for reproductive health are developed.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Organon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Organon Comparisons
Competitors of Organon
Organon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Organon
Frequently Asked Questions about Organon
Where is Organon located?
Organon is headquartered in Jersey City, United States. It is registered at Jersey City, New Jersey, United States.
What does Organon do?
Organon is dedicated to advancing womens health through a diverse portfolio of over 70 medicines and devices. Focus areas include reproductive health, maternal conditions, and contraception, alongside biosimilars and established brands in cardiovascular, neurology, and dermatology sectors. Therapies are delivered to over 140 markets worldwide, addressing conditions unique to women or affecting them disproportionately. Solutions are developed to support women at all life stages, ensuring accessible healthcare options for patients and providers.
Who are the top competitors of Organon?
Organon's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Organon offer?
Organon offers Women's Health Solutions, Biosimilars, and Established Brands.
Is Organon publicly traded?
Yes, Organon is publicly traded on NYSE under the ticker symbol OGN.
How many acquisitions has Organon made?
Organon has made 4 acquisitions, including Alydia Health, Dermavant, and Forendo Pharma.
Who are Organon's investors?
Organon has 1 investor. Key investors include Merck.
What is Organon's ticker symbol?
The ticker symbol of Organon is OGN on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.